{"id":"https://openalex.org/W2000367359","doi":"https://doi.org/10.1016/s0009-9236(98)90038-8","title":"Blunted 5 -HT1A-receptor agonist-induced corticotropin and cortisol responses after long- term ipsapirone and fluoxetine administration to healthy subjects*","display_name":"Blunted 5 -HT1A-receptor agonist-induced corticotropin and cortisol responses after long- term ipsapirone and fluoxetine administration to healthy subjects*","publication_year":1998,"publication_date":"1998-04-01","ids":{"openalex":"https://openalex.org/W2000367359","doi":"https://doi.org/10.1016/s0009-9236(98)90038-8","mag":"2000367359","pmid":"https://pubmed.ncbi.nlm.nih.gov/9585797"},"language":"en","primary_location":{"id":"doi:10.1016/s0009-9236(98)90038-8","doi":"https://doi.org/10.1016/s0009-9236(98)90038-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(98)90038-8","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074251150","display_name":"Ivan Berlin","orcid":"https://orcid.org/0000-0002-5928-5616","observed_orcids":["https://orcid.org/0000-0002-5928-5616"]},"institutions":[{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]},{"id":"https://openalex.org/I4210166400","display_name":"Bayer (France)","ror":"https://ror.org/05cm0es58","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210166400","https://openalex.org/I67348948"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ivan Berlin","raw_affiliation_strings":["Department of Pharmacology, Pit\u00e9-Salp\u00eati\u00e8re University Hospital, Paris, France","Bayer Pharma Puteaux France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Pit\u00e9-Salp\u00eati\u00e8re University Hospital, Paris, France","institution_ids":["https://openalex.org/I4210121705"]},{"raw_affiliation_string":"Bayer Pharma Puteaux France","institution_ids":["https://openalex.org/I4210166400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111702773","display_name":"Dominique Warot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166400","display_name":"Bayer (France)","ror":"https://ror.org/05cm0es58","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210166400","https://openalex.org/I67348948"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Dominique Warot","raw_affiliation_strings":["Bayer Pharma Puteaux France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma Puteaux France","institution_ids":["https://openalex.org/I4210166400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065498011","display_name":"Val\u00e9rie Legout","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166400","display_name":"Bayer (France)","ror":"https://ror.org/05cm0es58","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210166400","https://openalex.org/I67348948"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Val\u00e9rie Legout","raw_affiliation_strings":["Bayer Pharma Puteaux France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma Puteaux France","institution_ids":["https://openalex.org/I4210166400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075578239","display_name":"S Guillemant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166400","display_name":"Bayer (France)","ror":"https://ror.org/05cm0es58","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210166400","https://openalex.org/I67348948"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Serge Guillemant","raw_affiliation_strings":["Bayer Pharma Puteaux France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma Puteaux France","institution_ids":["https://openalex.org/I4210166400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109992783","display_name":"G\u00fcnther Sch\u00f6llnhammer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166400","display_name":"Bayer (France)","ror":"https://ror.org/05cm0es58","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210166400","https://openalex.org/I67348948"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"G\u00fcnther Sch\u00f6llnhammer","raw_affiliation_strings":["Bayer Pharma Puteaux France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma Puteaux France","institution_ids":["https://openalex.org/I4210166400"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024806046","display_name":"Alain Jacques Puech","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166400","display_name":"Bayer (France)","ror":"https://ror.org/05cm0es58","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210166400","https://openalex.org/I67348948"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Alain Puech","raw_affiliation_strings":["Bayer Pharma Puteaux France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma Puteaux France","institution_ids":["https://openalex.org/I4210166400"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":1.4565,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.76981132,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":96},"biblio":{"volume":"63","issue":"4","first_page":"428","last_page":"436"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.012400000356137753,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-ht1a-receptor-agonist","display_name":"5-HT1A receptor agonist","score":0.8399999737739563},{"id":"https://openalex.org/keywords/ipsapirone","display_name":"ipsapirone","score":0.9800000190734863},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/acth","display_name":"ACTH","score":0.8399999737739563},{"id":"https://openalex.org/keywords/cortisol","display_name":"cortisol","score":0.9639999866485596},{"id":"https://openalex.org/keywords/hypothalamic-pituitary-adrenal-axis","display_name":"hypothalamic-pituitary-adrenal axis","score":0.953000009059906},{"id":"https://openalex.org/keywords/hypothermic-response","display_name":"hypothermic response","score":0.6949999928474426},{"id":"https://openalex.org/keywords/long-term-antidepressant-treatment","display_name":"long-term antidepressant treatment","score":0.6359999775886536},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.4259999990463257},{"id":"https://openalex.org/keywords/receptor-desensitization","display_name":"receptor desensitization","score":0.6460000276565552},{"id":"https://openalex.org/keywords/controlled-release-formulation","display_name":"controlled-release formulation","score":0.43700000643730164},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.4399999976158142},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.4020000100135803}],"concepts":[{"id":"https://openalex.org/C2778362415","wikidata":"https://www.wikidata.org/wiki/Q6065448","display_name":"Ipsapirone","level":5,"score":0.9793763160705566},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7318958640098572},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7182232141494751},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7026033997535706},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.6399835348129272},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4838103652000427},{"id":"https://openalex.org/C2778709874","wikidata":"https://www.wikidata.org/wiki/Q190875","display_name":"Hydrocortisone","level":2,"score":0.451884388923645},{"id":"https://openalex.org/C2780546910","wikidata":"https://www.wikidata.org/wiki/Q185690","display_name":"Adrenocorticotropic hormone","level":3,"score":0.42572158575057983},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33314526081085205},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2112675905227661},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.21107390522956848},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.20121845602989197},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2777287423","wikidata":"https://www.wikidata.org/wiki/Q412194","display_name":"Buspirone","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000324","descriptor_name":"Adrenocorticotropic Hormone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006854","descriptor_name":"Hydrocortisone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0009-9236(98)90038-8","doi":"https://doi.org/10.1016/s0009-9236(98)90038-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(98)90038-8","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:9585797","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9585797","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2030375265","https://openalex.org/W1975125001","https://openalex.org/W2006731124","https://openalex.org/W1999982091","https://openalex.org/W1976438981","https://openalex.org/W2015082811","https://openalex.org/W1995958976","https://openalex.org/W2029391112","https://openalex.org/W1990913217","https://openalex.org/W2064446568"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"assess":[2],"whether":[3,29],"acute":[4],"5-hydroxytryptamine-1A":[5],"(5-HT1A)-receptor-mediated":[6],"corticotropin,":[7],"cortisol,":[8,187,213],"and":[9,23,28,52,77,125,128,133,156,170,192,229,299,307,316],"temperature":[10],"responses":[11,231],"are":[12,31],"maintained":[13],"after":[14,33,78,136,274],"3":[15],"weeks":[16,223,273],"of":[17,35,81,152,224,267,276,280,297,314,328,334],"treatment":[18,74,82,269],"with":[19,26,64,83,138,206,325],"controlled-release":[20],"(CR)":[21],"ipsapirone":[22,48,61,67,87,111,141,164,179,233,243,257,300],"fluoxetine":[24,92,193,298],"compared":[25,205],"placebo":[27,55,104,207,225],"changes":[30],"reversible":[32],"cessation":[34,275],"treatment.":[36,277],"METHODS:":[37],"This":[38,332],"was":[39,71,114],"a":[40,57,106,320],"randomized":[41],"parallel-group":[42],"study.":[43],"Ten":[44],"healthy":[45,284],"subjects":[46,102,285],"received":[47,54,103],"CR":[49,180],"or":[50,89,271],"fluoxetine,":[51],"eight":[53],"in":[56,105,130,167,176,238,247,310],"double-blind":[58],"manner.":[59,108],"An":[60],"challenge":[62,112,137],"test":[63,113],"20":[65,79,90,139,150],"mg":[66,140],"immediate-release":[68],"formulation":[69],"(IR)":[70],"performed":[72,115],"before":[73,161,262],"(day":[75,93],"0)":[76],"days":[80,151],"placebo,":[84],"80":[85],"mg/day":[86,91],"CR,":[88],"21).":[94],"From":[95],"day":[96,99,117],"22":[97],"to":[98,232,256,282,289],"34":[100,209],"all":[101,239,248],"simple-blind":[107],"A":[109],"third":[110],"on":[116],"35.":[118],"RESULTS:":[119],"Before":[120],"treatment,":[121,153,263],"resting":[122,304],"plasma":[123,131,154,168,227,305],"corticotropin":[124,132,155,169,228,306,315],"cortisol":[126,134,157,171,200,230,308,317],"concentrations":[127,135,158,172,244,309],"increases":[129,166],"IR":[142,234,258],"were":[143,159,173,245],"similar":[144,160,246],"for":[145],"the":[146,178,265,268,283,311],"three":[147,240],"groups.":[148,241],"After":[149,221],"challenge,":[162],"but":[163],"IR-induced":[165],"significantly":[174],"lower":[175],"both":[177],"group":[181,194],"(corticotropin,":[182,208],"6.5":[183],"+/-":[184,189,197,202,210,215,219],"2":[185,198,216,222,272],"pg/ml;":[186,199,212],"1.5":[188,201],"0.7":[190,203],"micrograms/dl)":[191,204],"(corticotropin":[195],"4.4":[196],"14":[211],"5.8":[214],"micrograms/dl,":[217],"mean":[218],"SEM).":[220],"administration,":[226],"again":[235],"became":[236],"identical":[237],"Plasma":[242],"groups":[249],"during":[250],"each":[251],"challenge.":[252],"The":[253],"hypothermic":[254],"response":[255],"showed":[259],"no":[260],"difference":[261],"at":[264],"end":[266],"period,":[270],"Long-term":[278,295],"administration":[279,296,327],"antidepressants":[281],"did":[286,301],"not":[287,302],"lead":[288],"any":[290],"serious":[291],"adverse":[292],"effects.":[293],"CONCLUSIONS:":[294],"influence":[303],"morning.":[312],"Stimulation":[313],"release":[318],"by":[319],"selective":[321],"5-HT1A-agonist":[322],"is":[323,337],"reduced":[324],"long-term":[326],"these":[329],"serotoninergic":[330],"antidepressants.":[331],"subsensitivity":[333],"postsynaptic":[335],"5-HT1A-receptors":[336],"reversible.":[338]},"counts_by_year":[{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}